<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02299856</url>
  </required_header>
  <id_info>
    <org_study_id>150/13.2</org_study_id>
    <nct_id>NCT02299856</nct_id>
  </id_info>
  <brief_title>Cardiac Magnetic Resonance in Acute Myocarditis</brief_title>
  <official_title>Cardiac Magnetic Resonance in Acute Myocarditis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac magnetic resonance (MR) is an established noninvasive diagnostic tool for detection
      of acute myocarditis. Diagnosis of myocarditis at 1.5T is currently made with the help of the
      Lake Louise Criteria (two of three criteria have to be positive in order to establish the
      diagnosis). Although these criteria are accepted and widely used in clinical routine, several
      disadvantages exist. Newer parameters like myocardial T1 and T2 mapping, extracellular volume
      fraction (ECV) and myocardial strain analysis have the potential to complement or even
      replace some of the Lake Louise Criteria and further enhance the diagnostic performance of
      cardiac MR in patients suspected of having acute myocarditis. The aim of our study is to
      evaluate the diagnostic performance of a comprehensive cardiac MR protocol in patients with
      acute myocarditis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial T1 relaxation time</measure>
    <time_frame>Measurement will be performed within 2 weeks after MRI scan.</time_frame>
    <description>Changes in myocardial T1 relaxation time is of interest in patients with acute myocarditis. T1 relaxation times will be directly obtained from the T1 maps through ROI analysis. T1 maps will be analyzed using a segmental approach. T1 relaxation times are given in [ms].</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial T2 relaxation time</measure>
    <time_frame>Measurement will be performed within 2 weeks after MRI scan.</time_frame>
    <description>Changes in myocardial T2 relaxation time is of interest in patients with acute myocarditis. T2 relaxation times will be directly obtained from T2 maps through ROI analysis. T2 maps will be analyzed using a segmental approach. T2 relaxation times are given in [ms].</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial ECV measurements</measure>
    <time_frame>Measurement will be performed within 2 weeks after MRI scan.</time_frame>
    <description>Changes in myocardial ECV parameters is of interest in patients with acute myocarditis. Hematocrit corrected ECV will be calculated using pre- and post-contrast T1 values for myocardium and blood pool using following formula:
ECV= (1⁄T1 &quot;myocardium post contrast&quot;-1⁄T1 &quot;myocadium pre contrast&quot;)/(1⁄T1 &quot;blood post contrast&quot;-1⁄ T1 &quot;blood pre contrast&quot;) x (1-hematocrit).
ECV is given in percentage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial strain analysis (focussed on longitudinal strain)</measure>
    <time_frame>Measurement will be performed within 2 weeks after MRI scan.</time_frame>
    <description>Changes in longitudinal strain as determined by echocardiography has been described in patient with acute myocarditis. In our study longitudinal strain is measured using feature tracking, which allows for strain calculation from standard MR cine datasets.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">84</enrollment>
  <condition>Myocarditis</condition>
  <arm_group>
    <arm_group_label>Myocarditis</arm_group_label>
    <description>Patients with strong clinical evidence for acute myocarditis (recent infection, elevated troponin and white blood cell count).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Healthy volunteers without any signs of cardiac disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac magnetic resonance scan</intervention_name>
    <arm_group_label>Myocarditis</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Hematocrit is obtained prior to cardiac MR.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients are included in the myocarditis group if they showed clinical evidence of acute
        myocarditis(acute chest pain, history of viral infection, elevated white blood cell count,
        ECG changes and/or elevated troponin).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No past medical history of cardiac disease.

          -  No cardiovascular risk factors (e.g. diabetes or hypertension)

        Exclusion Criteria:

          -  Contraindications for cardiac MR
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Bonn, Dept. of Radiology</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Luetkens JA, Doerner J, Thomas DK, Dabir D, Gieseke J, Sprinkart AM, Fimmers R, Stehning C, Homsi R, Schwab JO, Schild H, Naehle CP. Acute myocarditis: multiparametric cardiac MR imaging. Radiology. 2014 Nov;273(2):383-92. doi: 10.1148/radiol.14132540. Epub 2014 Jun 6.</citation>
    <PMID>24910904</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2014</study_first_submitted>
  <study_first_submitted_qc>November 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>December 9, 2015</last_update_submitted>
  <last_update_submitted_qc>December 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Bonn</investigator_affiliation>
    <investigator_full_name>Claas P. Naehle</investigator_full_name>
    <investigator_title>PD Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Diagnostic Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocarditis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

